Skip to main content

Table 2 Associations between vimentin and E-cadherin coexpression and other clinicopathological factors in pNETs

From: High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors

Variable Total, n Vimentin and E-cadherin expression pattern, n  
High vimentin and lost E-cadherin Other P
Age, years     0.291
  ≤ 60 156 26 130  
  > 60 71 16 55  
Sex     0.390
 Male 100 21 79  
 Female 127 21 106  
Symptoms     0.407
 Absent 94 15 79  
 Present 133 27 106  
Tumor size, cm     0.107
  ≤ 2 101 14 87  
  > 2 126 28 98  
Tumor location     0.505
 Head/uncinate/neck 103 21 82  
 Body/tail 124 21 103  
T-stage     0.769
 T1–2 180 34 146  
 T3–4 47 8 39  
LN metastasis     < 0.001
 Absent 203 30 173  
 Present 24 12 12  
Distant metastasis     0.003
 Absent 218 37 181  
 Present 9 5 4  
Perineural invasion     0.034
 Absent 204 34 170  
 Present 23 8 15  
WHO classification     0.111
 Grade 1 117 17 100  
 Grade 2 110 25 85  
AJCC stage     < 0.001
 I-II 193 26 167  
 III-IV 34 16 18  
  1. pNETs Pancreatic neuroendocrine tumors, LN Lymph node, AJCC American Joint Committee on Cancer
\